(Q40553537)

21 September 2017

Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children (English)

1 reference

21 September 2017

3

Afksendiyos Kalangos

1 reference

21 September 2017

5

Alain Gervaix

1 reference

21 September 2017

Maurice Beghetti

1

1 reference

PubMed ID

12887072

21 September 2017

Peter C Rimensberger

series ordinal

2

1 reference

PubMed ID

12887072

21 September 2017

Walid Habre

series ordinal

4

1 reference

21 September 2017

1 April 2003

1 reference

21 September 2017

Cardiology in the Young

1 reference

21 September 2017

13

1 reference

21 September 2017

2

1 reference

21 September 2017

161-167

1 reference

Systemic inflammatory response syndrome after cardiac operations.

21 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

High serum procalcitonin concentrations in patients with sepsis and infection

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Value of C-reactive protein in reflecting the magnitude of complement activation in children undergoing open heart surgery

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Interleukin-6 levels in serum and lung lavage fluid of children undergoing open heart surgery correlate with postoperative morbidity

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Procalcitonin as a marker for the early diagnosis of neonatal infection

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Procalcitonin in pediatrics: overview and challenge

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Kinetics of procalcitonin in iatrogenic sepsis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Postoperative plasma concentrations of procalcitonin after different types of surgery

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Inflammatory response to cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery-first results of the Procalcitonin in Heart Surgery study (ProHearts).

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

Value of C-reactive protein in detecting complications after open-heart surgery in children

1 reference

https://api.crossref.org/works/10.1017%2FS1047951103000301

7 January 2021

10.1017/S1047951103000301

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

12887072